China SXT Pharmaceuticals, Inc. announced that on November 24, 2020, Mr. Tulin Lu resigned from his position as a director of the Company for personal reasons. The board of directors of the Company appointed Mr. Yuan as a director to fill in the vacancy created by the resignation of Mr. Lu effective upon closing of the offering contemplated by the SPA, provided that, Mr. Yuan will cease to be a member of the board once he holds less than 1,200,000 Ordinary Shares.